Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 414 for “"Biologics"”.

  1. Development of Novel Antiangiogenic Biologics

    Current anti-VEGF biologics, such as bevacizumab and VEGF trap, have been successfully used as therapeutic agents for cancer and age-related macular degeneration (AMD). Since these strategies target VEGF systemically, their toxicity profile, including proteinuria and thromboembolic events, and need …

    toronto-retro Repository record for Development of Novel Antiangiogenic Biologics (opens in a new tab)

  2. Alternative drying technologies for biologics

    … drying) to alternative drying technologies for biologics. Vacuum foam-drying was identified as an alternative drying technology for biologics. Vacuum foam-drying is a drying technique that involves solvent removal by evaporation, at lowered pressure and ambient temperatures. Thus, vacuum …

    lund Repository record for Alternative drying technologies for biologics (opens in a new tab) Download PDF for Alternative drying technologies for biologics (opens in a new tab)

  3. Stealth Polymer Conjugates of Biologics

    <p>Biologics are potent, highly specific, and well-tolerated and have become an important class of drugs. Despite their promise, most of them have a short half-life due to rapid renal elimination and in vivo degradation. Their short in vivo half-life hence necessitates frequent injections, …

    duke Repository record for Stealth Polymer Conjugates of Biologics (opens in a new tab)

  4. Biomarkers and Biologics in Chronic Rhinosinusitis

    … field. This thesis focuses on biomarkers and biologics in CRS. Firstly, identifying and assessing clinical biomarkers that are available to the guide management in patients with CRS and eCRS. Secondly, a prospective open-label single-arm single-centre study of the effectiveness of mepolizumab …

    unsw Repository record for Biomarkers and Biologics in Chronic Rhinosinusitis (opens in a new tab)

  5. Mining Marine Environments for Novel Antimicrobial Biologics

    Deaths attributable to antimicrobial resistance (AMR) are predicted to rise from 700,000 per year now to 10 million by 2050. There is an urgent need for new antibiotics to meet the threat posed by AMR; the WHO recently reported that there are not enough antibiotics in development to meet this need. …

    plymouth Repository record for Mining Marine Environments for Novel Antimicrobial Biologics (opens in a new tab)

  6. Developing integrated downstream processes for next-generation biologics

    Manufacturing of biopharmaceuticals is a costly and time consuming process due to its inherent complexity and variability. The downstream process is the most expensive part and it involves multiple non-trivial steps. Continuous integrated manufacturing is a new concept that is encouraged by …

    lund Repository record for Developing integrated downstream processes for next-generation biologics (opens in a new tab) Download PDF for Developing integrated downstream processes for next-generation biologics (opens in a new tab)

  7. Proteomic Investigations of Therapeutic Biologics by Mass Spectrometry

    Biologics are a growing class of therapeutics that differ from traditional small molecules drugs in that they are typically produced a microorganism or by cellular processes. Biologics can include a variety of therapeutics including monoclonal antibodies, therapeutic proteins, viruses, etc. The …

    buffalo Repository record for Proteomic Investigations of Therapeutic Biologics by Mass Spectrometry (opens in a new tab)

  8. Advancing Sub-Visible Particle Characterization in Inhaled Biologics

    Protein-based therapeutics represent one of the fastest growing sectors in the phar maceutical industry, offering highly specific and effective treatment options for a range of diseases. However, their structural complexity makes them particularly vulnerable to instability and aggregation, …

    chalmers Repository record for Advancing Sub-Visible Particle Characterization in Inhaled Biologics (opens in a new tab)

  9. Development of biologics for use in translational medicine

    In this research, we developed a wide range of biological tools against two distinct targets from future diagnostic or therapeutic points of view. Firstly, we demonstrate that sporadic canine B cell lymphoma mimics the features of human equivalents which in turn will be advantageous for development …

    edinburgh Repository record for Development of biologics for use in translational medicine (opens in a new tab)

  10. Deep-sea discovery - mining marine environments for novel biologics.

    Global antimicrobial resistance will change the face of modern medicine, and the discovery of novel antimicrobials is one of the many solutions to this challenge. Furthermore, expanding antimicrobial natural product discovery to poorly explored ecological habitats may lead to the identification of …

    plymouth Repository record for Deep-sea discovery - mining marine environments for novel biologics. (opens in a new tab)

  11. Persistent Biologics: An ethnography of cancer immunotherapy in Cuba

    This thesis examines the emergence of cancer immunotherapy in Cuba based on an analysis of the intellectual, organisational, and material conditions of the biomedical landscape at the Centre of Molecular Immunology (CIM), Havana. Drawing on six months fieldwork inside and outside of CIM, the thesis …

    kings Repository record for Persistent Biologics: An ethnography of cancer immunotherapy in Cuba (opens in a new tab) Download PDF for Persistent Biologics: An ethnography of cancer immunotherapy in Cuba (opens in a new tab)

  12. Review of drug and biologics recalls: 2009 through 2019

    This study analyzed drugs and biologics recalls for the period of 2009 and 2019. The data used in the study was generated from Food and Drug Administration records. A total of 466 drugs and 84 biologics were recalled during the 11-year period. The common causes of drug product recalls included …

    emich Repository record for Review of drug and biologics recalls: 2009 through 2019 (opens in a new tab)

  13. Investigating the rules governing N-linked glycosylation of Biologics

    Biologics, drugs produced in living organisms, such as monoclonal antibodies (mAbs) can treat various medical conditions, so improving their production and efficacy is important. Large scale mAb manufacturing involves expressing recombinant DNA in mammalian cells, for example Chinese hamster ovary …

    whiterose Download PDF for Investigating the rules governing N-linked glycosylation of Biologics (opens in a new tab)

  14. Ex-Vivo Injection of Biomaterial Biologics for Treatment of Osteonecrosis

    BACKGROUND: A loss of blood flow to bone produces osteonecrosis, characterized by cell necrosis and tissue destruction. This necrotic microenvironment induces chronic inflammation, poor bone regeneration, joint deformity, osteoarthritis, and potentially a total joint replacement. One potential …

    utswmed Repository record for Ex-Vivo Injection of Biomaterial Biologics for Treatment of Osteonecrosis (opens in a new tab)

  15. The Development of Local-acting Biologics to Treat Rheumatoid Arthritis

    … and progressive joint destruction. Anti-TNF biologics have been developed to treat RA and although effective in the majority of patients, they require repeated administration and systemically inhibit TNF. This systemic inhibition leads to systemic immune suppression and can result in …

    toronto-retro Repository record for The Development of Local-acting Biologics to Treat Rheumatoid Arthritis (opens in a new tab)

Page 1 of 21